| Financial Year |
March 31 2023 |
| Monetary Funds |
4,134,536,596.33 |
| Held-for-trading Financial Assets |
31,213,950.58 |
| Notes Receivable |
-- |
| Accounts Receivable |
11,871,527.86 |
| Advances to Suppliers |
333,878,690.88 |
| Other Receivables |
34,129,738.37 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,073,457,155.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
50,000,000.00 |
| Other Current Assets |
30,355,918.52 |
| Total Current Assets |
5,699,443,578.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
973,435,812.64 |
| Investment Properties |
-- |
| Fixed Assetes |
2,064,452,215.18 |
| Under-construction Projects |
459,523,048.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
733,360,047.71 |
| R&D expenses |
-- |
| Goodwill |
131,734,352.10 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
82,219,450.78 |
| Other Non-Current Assets |
308,240,510.93 |
| Sub-Total of Non-Current Assets |
4,766,829,244.66 |
| Total Assets |
10,466,272,822.68 |
| Short-Term Loans |
241,578,222.22 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,837,615,597.28 |
| Accounts Payable |
376,929,817.87 |
| Accounts Received In Advance |
4,121,162.60 |
| Employee Compensation Payable |
146,394,737.96 |
| Taxes Payable |
56,659,250.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
179,070,051.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
82,475,389.27 |
| Sub-Total of Current Liabilities |
3,913,930,085.70 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,049,380.01 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
201,629,360.89 |
| Total Liabilities |
4,115,559,446.59 |
| Paid-In Capital(Or Share Stock) |
1,156,884,000.00 |
| Capital Surplus |
296,172,863.43 |
| Surplus Reserve |
377,422,401.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,732,240,593.55 |
| Minority Stockholder's Interest |
697,315,774.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,653,397,601.94 |
| Owner's Equity（Stockholder's Equity） |
6,350,713,376.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,466,272,822.68 |
